Home Cart 0 Sign in  
X

[ CAS No. 110522-75-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 110522-75-3
Chemical Structure| 110522-75-3
Chemical Structure| 110522-75-3
Structure of 110522-75-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 110522-75-3 ]

Related Doc. of [ 110522-75-3 ]

Alternatived Products of [ 110522-75-3 ]
Product Citations

Product Details of [ 110522-75-3 ]

CAS No. :110522-75-3 MDL No. :MFCD00079383
Formula : C13H19N3O5 Boiling Point : -
Linear Structure Formula :- InChI Key :PDTIVAGPIHEWDX-IQJOONFLSA-N
M.W : 297.31 Pubchem ID :688503
Synonyms :
N4-Isobutyryl-2'-deoxycytidine
Chemical Name :N-(1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)isobutyramide

Calculated chemistry of [ 110522-75-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.62
Num. rotatable bonds : 5
Num. H-bond acceptors : 6.0
Num. H-bond donors : 3.0
Molar Refractivity : 74.21
TPSA : 113.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.08 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.95
Log Po/w (XLOGP3) : 0.05
Log Po/w (WLOGP) : -1.04
Log Po/w (MLOGP) : -1.23
Log Po/w (SILICOS-IT) : -0.51
Consensus Log Po/w : -0.35

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.6
Solubility : 7.53 mg/ml ; 0.0253 mol/l
Class : Very soluble
Log S (Ali) : -1.99
Solubility : 3.04 mg/ml ; 0.0102 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.96
Solubility : 32.5 mg/ml ; 0.109 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.88

Safety of [ 110522-75-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 110522-75-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 110522-75-3 ]

[ 110522-75-3 ] Synthesis Path-Downstream   1~16

  • 1
  • [ 40615-36-9 ]
  • [ 110522-75-3 ]
  • [ 100898-62-2 ]
YieldReaction ConditionsOperation in experiment
60%
  • 2
  • [ 110522-75-3 ]
  • [ 22882-02-6 ]
  • [ 951-77-9 ]
YieldReaction ConditionsOperation in experiment
0.7 % Chromat. With ammonia; methylamine In water at 65℃; for 1h; deprotection reagent;
  • 3
  • [ 110522-80-0 ]
  • [ 110522-75-3 ]
YieldReaction ConditionsOperation in experiment
With pyridine; water; triethylamine
  • 5
  • [ 110522-75-3 ]
  • Imidazole-1-carboxylic acid 1-(3,5-dimethoxy-phenyl)-2-oxo-2-phenyl-ethyl ester; compound with trifluoro-methanesulfonic acid [ No CAS ]
  • Carbonic acid 1-(3,5-dimethoxy-phenyl)-2-oxo-2-phenyl-ethyl ester (2R,3S,5R)-3-hydroxy-5-(4-isobutyrylamino-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
50% With pyridine at 25℃; for 8h;
  • 6
  • [ 110522-75-3 ]
  • [ 951-77-9 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide In methanol; water for 0.02h; microwave irradiation;
  • 7
  • [ 110522-75-3 ]
  • [ 156876-26-5 ]
  • [ 156876-23-2 ]
YieldReaction ConditionsOperation in experiment
With pyridine In dichloromethane at -15 - 20℃;
YieldReaction ConditionsOperation in experiment
With ammonia Ambient temperature; The half time of N-deprotection was measured. New cytosine protecting group useful in oligonucleotide synthesis was proposed.;
  • 10
  • [ 110522-75-3 ]
  • N4-isobutyl-2'-deoxycytidine [ No CAS ]
YieldReaction ConditionsOperation in experiment
82% Stage #1: N4-isobutyryll-2'-deoxycytidine With N,O-bis-(trimethylsilyl)-acetamide; triethylamine-borane In tetrahydrofuran at 25℃; for 2h; Stage #2: With ammonia In water at 55℃; for 12h;
  • 11
  • [ 110522-75-3 ]
  • [ 179691-31-7 ]
  • 2'-deoxy-N4-isobutyrylcytidine 5'-[2-(2-nitrophenyl)propyl carbonate] [ No CAS ]
YieldReaction ConditionsOperation in experiment
0.307 g With pyridine In dichloromethane at -50 - -20℃; for 5h;
  • 12
  • [ 110522-75-3 ]
  • Carbonic acid (2R,3S,5R)-3-[(2-cyano-ethoxy)-diisopropylamino-phosphanyloxy]-5-(4-isobutyrylamino-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-2-ylmethyl ester 1-(3,5-dimethoxy-phenyl)-2-oxo-2-phenyl-ethyl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 50 percent / pyridine / 8 h / 25 °C 2: 70 percent / diisopropylethylamine / CH2Cl2 / 25 °C
  • 13
  • [ 110522-75-3 ]
  • Diisopropyl-phosphoramidic acid (2R,3S,5R)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-5-(4-isobutyrylamino-2-oxo-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 2-cyano-ethyl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 2: diisopropylammonium tetrazolidate / CH2Cl2
  • 14
  • [ 110522-75-3 ]
  • [ 110808-24-7 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 2: pyridine / acetonitrile
  • 15
  • [ 951-77-9 ]
  • [ 110522-75-3 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: pyridine 2: triethylamine, water, pyridine
  • 16
  • [ 110522-75-3 ]
  • [ 110522-84-4 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 60 percent
Recommend Products
Same Skeleton Products
Historical Records
; ;